Mr. Ware is an attorney in private practice. Mr. Ware is a former partner in the New York-based firm of Chadbourne & Parke LLP. He served as general counsel to several other companies where Dr. Steiner was the founder and CEO. Mr. Ware is a member of New York and Florida Bars.

Dr. Steiner is the founder and CEO of three publicly-traded drug delivery companies: Biodel Inc. (Nasdaq: BIOD), MannKind Corp. (Nasdaq: MNKD), and Emisphere Technologies, Inc. (OTCQB: EMIS). Prior to joining Perosphere, Dr. Steiner served as Biodel’s Chairman, President and Chief Executive Officer from its inception in December 2003 through March of 2010.

Dr. Mathiowitz is a tenured Professor of Medical Science and Engineering, and the Director of the Biotechnology graduate program in Brown's Department of Molecular Pharmacology, Physiology & Biotechnology. She was the founder of Spherics, Inc., the editor of The Encyclopedia of Controlled Drug Delivery Systems (1999), and serves as an editorial board member for five journals.

Dr. Costin is the former Corporate Vice President of Scientific and Medical Affairs at Carter-Wallace, Inc. Dr. Costin worked on the development of Organidin, Soma, Rynatan, Felbatol, Taurolidine, Tenormin, Tenoretic, Nolvadex, Zestril, Vascor, among other drugs. He has an M.D. from Emory University School of Medicine.

Mr. Sussman is Managing Partner at The Channel Group, LLC. He served as CFO or senior management of public and private biotechnology companies including Perlegen Sciences, Inc., Memory Pharmaceuticals Corp., and Cadus Pharmaceutical Corp. He received a B.S. in Physics from Stony Brook University, an M.S. in Biotechnology from Manhattan College, and an S.M. in Management from the Sloan School of Management, MIT.

Mr. van Straelen is the former President of U.S. Operations and Executive Vice President for Worldwide Sales and Marketing for Akzo Nobel N.V.’s business unit, Diosynth, the largest manufacturer of heparin for pharmaceutical use. He received an M.Sc. in Biochemistry from the University of Amsterdam.

Dr. Bakhru is a Postdoctoral Fellow with Dr. Mathiowitz at Brown University, and winner of the 2008 Global MOOT Corp competition. Dr. Bakhru has co-authored over 20 publications, eight patents and one book chapter; his work has been published in 40 conference proceedings and abstracts. Dr. Bakhru received a B.S. in Biomedical Engineering from Columbia University, an M.S.E from Johns Hopkins University in Materials Science and a Ph.D. from CMU.

Dr. Laulicht is a Postdoctoral Fellow in the Harvard-MIT Health Sciences Technology program in the laboratories of Dr. Robert Langer and Dr. Jeffrey Karp. Dr. Laulicht has co-authored six publications, 11 patents and one book chapter. Dr. Laulicht received a BA in Biophysics from Columbia University where he was an I.I. Rabi Science Research Scholar and a PhD in Medical Science from Brown, for which he won the Joukowsky Outstanding Dissertation.